WuXi Biologics to construct $60mn facility in Singapore

By Sophie Chapman
Share
The Chinese pharmaceutical manufacturer, WuXi Biologics, has announced it will be expanding its operations to Singapore. The company has confirmed it...

The Chinese pharmaceutical manufacturer, WuXi Biologics, has announced it will be expanding its operations to Singapore.

The company has confirmed it’s third manufacturing site in less than a month, with a S$80mn (US$60mn) facility in its first Asian city country outside of China.

The contract development and manufacturing organisation (CDMO) aims for the site to employ 150 members of staff when operational.

The facility will feature 4,500l of bioreactor capacity, made up of two 2,000l traditional fed-batch reactors and one 500l perfusion-based continuous processing capabilities.

The site has been designed to manage clinical and small-volume commercial production.

SEE ALSO:

The project has been financial backed the Singapore Economic Development board, who will contribute to the funding.

“We are all very excited to initiate our first overseas Asian site in Singapore to enable local companies and expedite biologics development in Asia,” announced Dr Chris Chen, CEO of WuXi Biologics.

“We are committed to becoming the most comprehensive capability and technology platform in the global biologics industry to enable both local and global partners.”

WuXi Biologics has recently announced it will be developing a biologics facility in Dundalk, Ireland, costing €325mn ($392mn).

Share

Featured Articles

Your Guide to Manufacturing LIVE Chicago

With just six months to go until Manufacturing LIVE Chicago, explore the highlights you can look forward to below

UPDATED VENUE & DATE – Manufacturing LIVE Chicago 2025

Manufacturing LIVE Chicago announces important changes to its venue and date for the co-located event with PSC LIVE and Sustainability LIVE in 2025

The Breakdown of the Global Plastics Treaty isn't the end

The failure of the INC-5 talks has caused anger across the manufacturing sector, but the breakdown of this treaty will not stop efforts to address plastic

Stellantis Plant Shutdown Confirms EV Manufacturing Concerns

Sustainability & ESG

The Highlights of the Rockwell Automation Fair 2024

Digital Factory

TFL Drives Future of Electrification With Buses on Route 358

Sustainability & ESG